Cargando…

Transcriptomic Analysis of Livers of Inactive Carriers of Hepatitis B Virus With Distinct Expression of Hepatitis B Surface Antigen

Inactive carrier phases in chronic hepatitis B virus (HBV) infection present minimal liver disease and HBV replication activity suggesting partial immune reconstitution, although the mechanisms responsible remain elusive. Moreover, hepatitis B surface antigen (HBsAg) production—hypothesized to modul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rico Montanari, Noe, Ramirez, Ricardo, Van Buuren, Nick, van den Bosch, Thierry P P, Doukas, Michail, Debes, Jose D, Feierbach, Becket, Boonstra, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921997/ https://www.ncbi.nlm.nih.gov/pubmed/34279652 http://dx.doi.org/10.1093/infdis/jiab381

Ejemplares similares

Differential gene expression, irrespective of circulating Hepatitis B Surface Antigen levels, between Inactive Carrier and Nucleos(t)ide Analogue-Treated Hepatitis B Virus patients
por: Montanari, Noé R, et al.
Publicado: (2020)

Hepatitis B Virus: Inactive carriers
por: Sharma, Sanjeev Kumar, et al.
Publicado: (2005)

Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels
por: Zeng, Qing-Lei, et al.
Publicado: (2020)

Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B
por: Brakenhoff, Sylvia M, et al.
Publicado: (2022)

Serum Galectin-3 Levels in Children with Chronic Hepatitis B Infection and Inactive Hepatitis B Carriers
por: Uluca, Ünal, et al.
Publicado: (2015)

Validation of Whole Blood Rapid Diagnosis Test for Hepatitis B
por: Debes, Jose D., et al.
Publicado: (2020)

Inactive Carriers of Hepatitis B Virus: A Never Ending Story
por: Macedo, Guilherme
Publicado: (2015)

Hepatitis B Virus Inactive Carriers: Which Follow-up Strategy?
por: Magalhães, Maria João, et al.
Publicado: (2015)

Immune dissociation during acute hepatitis E infection
por: Debes, Jose D., et al.
Publicado: (2019)

Dynamics of the Immune Response in Acute Hepatitis B Infection
por: Stelma, Femke, et al.
Publicado: (2017)

Efficacy of Influenza Vaccination in Patients with Cirrhosis and Inactive Carriers of Hepatitis B Virus Infection
por: Sayyad, B, et al.
Publicado: (2012)

Inactive Hepatitis B Carrier and Pregnancy Outcomes: A Systematic Review and Meta–analysis
por: KERAMAT, Afsaneh, et al.
Publicado: (2017)

Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B
por: van Buuren, Nicholas, et al.
Publicado: (2022)

Hepatitis B Surface Antigen Decline during Sofosbuvir and Ribavirin Therapy in Hepatitis B Inactive Carriers Who Were Co-infected with Hepatitis C
por: Sato, Shunsuke, et al.
Publicado: (2021)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
por: Aggarwal, Abhishek, et al.
Publicado: (2022)

Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo
por: Gorsuch, Cassandra L., et al.
Publicado: (2022)

Comparison of Vitamin D Levels in Naive, Treated, and Inactive Carriers with Chronic Hepatitis B Virus
por: Sali, Shahnaz, et al.
Publicado: (2016)

Inactive hepatitis B carriers: outcomes of patients followed at Hôpital Principal de Dakar, Senegal
por: Diallo, Ibrahima, et al.
Publicado: (2018)

Hepatitis B Virus-related Vasculitic Neuropathy in an Inactive Virus Carrier Treated with Intravenous Immunoglobulin
por: Kusama, Kaori, et al.
Publicado: (2020)

Analysis of the Efficacy and Safety of PEGylated Interferon-α2b Treatment in Inactive Hepatitis B Surface Antigen Carriers
por: Huang, Yan, et al.
Publicado: (2021)

The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
por: Rico Montanari, Noe, et al.
Publicado: (2021)

Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients
por: Ungtrakul, Teerapat, et al.
Publicado: (2017)

Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study
por: Demirturk, Nese, et al.
Publicado: (2014)

Evaluation of Rapid Diagnostic Tests for Assessment of Hepatitis B in Resource-Limited Settings
por: Leathers, James S., et al.
Publicado: (2019)

Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy
por: Burdette, Dara L, et al.
Publicado: (2022)

Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir
por: Cruchet, Romuald, et al.
Publicado: (2020)

Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study
por: Sonneveld, Milan J, et al.
Publicado: (2020)

The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers
por: Kim, Eun Sun, et al.
Publicado: (2011)

Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
por: Liu, Chun Jen, et al.
Publicado: (2021)

Low eligibility for hepatitis B treatment in the Brazilian public health system
por: Scarponi, Cristiane Faria Oliveira, et al.
Publicado: (2022)

Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001–2012
por: Moore, Miranda S, et al.
Publicado: (2018)

An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load
por: Ngo, Yen, et al.
Publicado: (2008)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements
por: Malagnino, Vincenzo, et al.
Publicado: (2018)

Prevalence and Clinical Significance of Occult Hepatitis B Infection in The Gambia, West Africa( )
por: Ndow, Gibril, et al.
Publicado: (2021)

Hepatitis B Vaccination Impact and the Unmet Need for Antiviral Treatment in Blantyre, Malawi( )
por: Stockdale, Alexander J, et al.
Publicado: (2021)

Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus
por: Sheikh, Daanish, et al.
Publicado: (2023)

Single hepatocytes show persistence and transcriptional inactivity of hepatitis B
por: Balagopal, Ashwin, et al.
Publicado: (2020)

Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients
por: Kamimura, Hiroteru, et al.
Publicado: (2022)

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load
por: Ngo, Yen, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j952c3ghptc789hgsn6pq5k48k